AKI after cardiac surgery is highly prevalent and prognostically important.
心脏手术后的急性肾损伤发生率很高，并且有预后的重要性。
Aki added: 'These ingredients [additives] are not genuine.
阿基补充道：“这些添加剂不正宗。”
Conclusions Incidence of AKI after LDLT is quite high and the prognosis is poor.
结论活体肝移植患者术后aki发生率高，AKI患者预后较差。
For patients in renal wards who have uncomplicated AKI, daily hemodialysis might be adequate.
对于肾脏病房没有并发症的AKI患者来说，日间血液透析可能已经足够。
All patients with clinical findings of AKI should have a renal panel and complete blood count with differential performed.
具有急性肾损伤临床症状之全体病人，应作肾功能测试及全血细胞计数，且作差异比较。
Objective To compare the RIFLE and AKIN diagnosis criteria for acute kidney injury (AKI) in patients undergoing cardiac surgery.
目的比较RIFLE与AKIN的急性肾损伤(aki)诊断标准在心脏手术患者中的应用价值。
Sepsis is the most common cause of acute kidney injury (AKI) in critical illness, but there is limited information on septic AKI.
脓毒血症是危重患者急性肾损伤最为常见的病因，但有关脓毒血症性急性肾损伤的资料非常有限。
Conclusion It is the key point to prevent AKI that pay more attention to control and intervene the risk factors of elder CKD patients.
结论重视老年慢性肾脏病患者高危因素的控制和积极干预，是预防其发生急性肾损伤的关键。
Primary outcomes were renal replacement therapy (RRT), author-defined kidney failure and acute kidney injury (AKI) as defined by the RIFLE criteria.
主要结局是肾替代疗法(RRT)，作者定义的肾衰竭和RIFLE标准定义的急性肾损伤(aki)。
Those with mild, moderate and severe AKI had a 15, 23 and 33 percent increased risk of death respectively after accounting for other known risk factors.
在排除其他危险因素干扰后发现，伴有轻、中、重度aki的患者死亡风险分别增加了15%，23%及33%。
The complexity of the patient who has AKI associated with multiple organ failure implies that CRRT should probably be the first-line treatment in ICU Settings.
合并有多器官衰竭的AKI患者的复杂性提示CRRT可能应当成为ICU单位的一线治疗。
Conclusion Compared to RIFLE criteria, AKIN criteria do not improve the sensitivity of diagnosis and predictive ability of hospital mortality of AKI after cardiac surgery.
结论与RIFLE标准比较，AKIN标准在对心脏手术后aki诊断的敏感性及患者院内死亡预测的精确性方面未显示出明显的优势。
The current evidence suggests that all HES products increase the risk in AKI and RRT in all patient populations and a safe volume of any HES solution has yet to be determined.
现有证据显示所有的羟乙基淀粉产品在所有的患者人群中都会增加急性肾损伤和肾脏替代治疗的风险，且羟乙基淀粉溶液的安全用量还没有被确定。
Objective: To evaluate the efficacy of continuous renal replacement therapy (CRRT) in patients with severe acute pancreatitis (SAP) complicating acute kidney injury (AKI) and its prognosis.
目的：观察连续性肾脏替代疗法(CRRT)治疗重症急性胰腺炎(SAP)合并急性肾损伤(aki)患者的疗效及预后。
Objective: To evaluate the efficacy of continuous renal replacement therapy (CRRT) in patients with severe acute pancreatitis (SAP) complicating acute kidney injury (AKI) and its prognosis.
目的：观察连续性肾脏替代疗法(CRRT)治疗重症急性胰腺炎(SAP)合并急性肾损伤(aki)患者的疗效及预后。
应用推荐